STANDARD BIOTOOLS INC. — Director's Dealing 2023

Apr 7, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2023-04-04

Reporting Person: Egholm Michael (Director, President & CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-04	Common Stock	M	196512	—	Acquired	206512	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-04-04	Restricted Stock Units	$	M	196512	Disposed		Common Stock (196512.0)	Direct

Footnotes

F1: Includes 5,000 shares of Common Stock purchased pursuant to Fluidigm Corporation (currently Standard BioTools Inc.) 2017 Employee Stock Purchase Plan ("ESPP") for the purchase period of June 1, 2022 to November 30, 2022.

F2: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.

F3: Restricted Stock Units vest in four equal annual installments beginning April 4, 2023.